PRESCRIBING INFORMATION - Baxter
The Dextrose Injections, USP products have value as a source of water and calories. They are capable of inducing diuresis depending on the clinical condition of the patient. File Size: 448KBPage Count: 15
Dextrose Glucose 10% IV Infusion - 500ml | Infusion ...
CachedGlucose 10% w/v Solution for Infusion is indicated for: • Supply of carbohydrate alone or, as required, during parenteral nutrition. • Prevention and treatment of hypoglycaemia.
Product Catalog - Baxter
CachedJan 1, 2024 · Infusion Systems and Specialized Patient Monitoring Large Volume Pumps (LVP) are used to deliver medication and solutions through various routes (e.g. Intravenous and epidural) for therapeutic and diagnostic purposes.
Package leaflet: Information for the patient - medicines
Glucose Intravenous Infusion 50% w/v is a sterile solution of glucose in water and is used to: restore blood glucose levels. provide temporary relief from the symptoms of a swollen brain and comas due to low blood sugar. correct high blood potassium levels. 2.
HIGHLIGHTS OF PRESCRIBING INFORMATION 5.3)
Dextrose Injection is indicated as source of water and calories and may also be used as diluent for reconstitution of a powdered or liquid (up to 10 mL) drug product packaged in a vial with a 20mmclosure.
50% Dextrose Injection, USP Concentrated Dextrose for ...
Cached50% Dextrose Injection, USP is a sterile, nonpyrogenic, hypertonic solution of dextrose in water for injection for intravenous injection as a fluid and nutrient replenisher. Each mL of fluid contains 0.5 g dextrose, hydrous which delivers 3.4 kcal/gram.
50% Dextrose Injection, USP Concentrated Dextrose for ... - DailyMed
dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=4ed365da-4e62-4329-c1b9-c197ab4fb6e1See all results for this question
Dextrose Injection
Dextrose injection without electrolytes should not be administered simultaneously with blood through the same infusion set because of the possibility that pseudo-agglutination of red cells may occur. WARNINGS . site of injection. Significant hyperglycemia and possible hyperosmolar syndrome may result from a too ra.
